Matthew Porteus
No más puestos en curso
Fortuna: 8 M $ al 31/05/2024
Perfil
Matthew Porteus is the founder of CRISPR Therapeutics AG, which was founded in 2013.
He is also the founder of Graphite Bio, Inc., which was founded in 2017.
Dr. Porteus's current job is as a Professor at Stanford University and as an Associate Professor at Stanford School of Medicine since 2010.
His former job was as an Assistant Professor at The University of Texas Southwestern Medical Center from 2003 to 2010.
Dr. Porteus's education includes an undergraduate degree from Harvard University and a doctorate from Stanford University.
Dr. Porteus is also the founder of Kamau Therapeutics, Inc...
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
1.97% | 01/02/2024 | 504 075 ( 1.97% ) | 8 M $ | 31/05/2024 |
Cargos activos de Matthew Porteus
| Empresas | Cargo | Inicio |
|---|---|---|
| Stanford School of Medicine | Corporate Officer/Principal | 01/10/2010 |
| Stanford University | Corporate Officer/Principal | - |
Antiguos cargos conocidos de Matthew Porteus.
| Empresas | Cargo | Fin |
|---|---|---|
| The University of Texas Southwestern Medical Center | Corporate Officer/Principal | 01/08/2010 |
| LENZ THERAPEUTICS, INC. | Fundador | - |
| CRISPR THERAPEUTICS AG | Fundador | - |
Formación de Matthew Porteus.
| Harvard University | Undergraduate Degree |
| Stanford University | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| CRISPR THERAPEUTICS AG | Health Technology |
| Empresas privadas | 1 |
|---|---|
Graphite Bio, Inc.
 Graphite Bio, Inc. BiotechnologyHealth Technology Graphite Bio, Inc. is a clinical-stage gene editing company. It engages in the business of developing therapies that harness targeted gene integration to treat or cure serious diseases. The company was founded by Matthew Porteus and Maria Grazia Roncarolo on June 1, 2017 and is headquartered in South San Francisco, CA. | Health Technology |
- Bolsa de valores
- Insiders
- Matthew Porteus
